台富製藥股份有限公司 | 合法醫療器材資訊網

最新情報與公告 · 聯絡我們 · H.U. Group 台富製藥股份有限公司為H.U. 集團的一員. Copyright(C) FUJIREBIO TAIWAN Inc. All rights reserved. 使用條款與須知. Read More

FUJIREBIO命名的由來. Fujizoki Pharmaceutical Co., Ltd (富士臓器製薬株式会社) 創立於1950 年，並於1983 年更名為Fujirebio Inc ... Read More

Fujirebio Diagnostics, Inc. 201 Great Valley Parkway Malvern, PA 19355-1308, U.S.A. +1 610.240.3800. FAX：+1 ... Read More

Since November 2020 Fujirebio Europe and CENTOGENE have partnered to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing in​... Read More

Find the right product. Or Browse: Product categories; Product brands; Product diseases. Product categories. Instruments. Our LUMIPULSE G, TENDIGO™, ... Read More

Today, we are an H.U. Group (previously Miraca Group) company, a global Japanese healthcare player that favors cross-group R&D synergies and expertise in ... Read More

For general remarks to Fujirebio please choose your regional Fujirebio headquarter at the bottom of our main contact page. Product information inquiries​. About ... Read More

Why work at Fujirebio? ... We are a leading international healthcare company that conceives, develops, produces and markets high quality in vitro diagnostics (IVD)​ ... Read More

Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform. Read ... Read More